See the minimum stack

Pillar

Cardiac Is the Number One Killer. Here Is What the Evidence Says to Do.

Cardiovascular disease is the leading cause of death, and the advice is always the same: watch your cholesterol, watch your ApoB. But plaque starts in a damaged vessel wall, and the wall runs on potassium, magnesium, vitamin E, vitamin C and the minerals most adults are short of.

11 min read

By The Holistic Hub Editorial CollectiveNov 1, 2026(updated Nov 1, 2026)

Sources listed

Cardiac is the number one killer, and the advice that comes with it is almost always the same: watch your cholesterol, watch your ApoB, take what you are given. Cardiovascular disease was the leading cause of death in the United States from 1990 to 2016 [1]Source, and worldwide it is responsible for 17.1 million deaths a year [2]DOI. Stroke, the other half of it, caused 6.55 million deaths in 2019, and high systolic blood pressure accounted for 55.5 percent of stroke disability [3]PubMed. Here is the part that never makes the poster: the numbers you are told to watch sit downstream of a vessel wall, and that wall runs on minerals and vitamins most adults are short of. Every claim below carries its source.

Cardiac is the number one killer. Here is what to do.

Stroke is the second leading cause of death and disability globally [4]PubMed, so the vessels are the story twice over. What to do starts with knowing what the problem is made of. A plaque is not a thing that appears from nowhere in a healthy artery. It builds in a wall that was already damaged, where the flow is wrong, where the lining has lost its protection, where the particles that carry cholesterol get trapped and oxidized. Each of those has a nutrient story with human trials behind it. We take them in order: the wall, the lining, the particles, the potassium and sodium balance, the kidney, stress and magnesium, vitamin E and vitamin C, the clot and the calcium, and then why the food and the blood test both mislead.

Plaque starts where the wall is damaged

Areas of low or turbulent blood flow damage the arterial lining and allow cholesterol and immune cells in, which is the start of atherosclerosis [5]PubMed. Disturbed flow regions with low shear stress, recirculation and oscillation are preferential sites of lesion formation, linked to how the endothelial cells sense the flow [6]PubMed. Retention and modification of apoB-containing lipoproteins in the wall are crucial early events in atherosclerosis initiation [7]PubMed, and increased endothelial permeability and LDL transport are early features, driven by oxidative stress [8]PubMed. Elevated plasma and blood viscosity were independently associated with incident coronary heart disease [9]Source. Read the sequence again: the flow, the lining, the permeability, the oxidative stress. ApoB is what gets trapped in a wall that was already damaged.

Your vessels are lined with something you were never told about

Most people have never heard of the glycocalyx. It is a carbohydrate layer on the inside of blood vessel walls, and it senses blood flow to trigger vasodilation and regulates immune cell traffic [10]PubMed. It senses flow forces and regulates vascular permeability and blood pressure [11]PubMed, and together with the epithelial sodium channel it acted as a shear stress sensor mediating vasodilation in endothelial cells [12]PubMed. High cholesterol, atherosclerosis and obesity break down the negatively charged glycocalyx, disrupting the barrier that keeps cholesterol and cells from the vessel wall [13]PubMed. A review of 93 studies linked glycocalyx degradation to impaired nitric oxide signaling, higher vascular permeability and microvascular dysfunction [14]DOI, and in 120 patients with atherosclerotic cardiovascular disease, higher glycocalyx-shedding markers went with disease severity on coronary and carotid imaging [15]DOI. In cultured endothelial cells, potassium softened the cell cortex and increased nitric oxide release while sodium stiffened it [16]PubMed.

Cholesterol is not good and bad

Cholesterol is carried. HDL protects against coronary heart disease by driving reverse cholesterol transport, removing excess cholesterol from tissues for excretion via the liver and bile [17]PubMed. The harm is in the particle that has been oxidized in the wall: atherosclerosis is driven by oxidized LDL particles in the artery wall, which macrophages take up to form foam cells [18]DOI, and LDL remnants, small dense LDL and oxidized LDL are pro-atherogenic [19]PubMed. Lipoprotein-specific transport of lipid oxidation products was strongly associated with atherosclerotic cardiovascular disease risk independent of cholesterol [20]PubMed. A number that counts particles tells you how many carriers there are. It does not tell you what they are carrying, or what protects them.

Potassium and sodium: the balance nobody measures

Pooling 32 randomized trials, higher potassium intake produced a dose-dependent reduction in blood pressure, with larger effects in people with hypertension [21]Source. A meta-analysis of 22 randomized trials found higher potassium intake lowered blood pressure in hypertension and was linked with a 24% lower stroke risk [22]PMC. Across 23 randomized trials, oral potassium reduced systolic pressure by 4.25 mmHg and diastolic by 2.53 mmHg [23]PubMed. The ratio counts as much as either number: a higher sodium-to-potassium ratio was associated with a 10% higher risk of cardiovascular events and mortality across 24 studies [24]DOI, and with higher cardiovascular and overall mortality among 416,104 men and women followed for over six million person-years [25]PubMed. In more than 10,000 US adults, higher sodium, lower potassium and a higher ratio were each associated with higher blood pressure and hypertension odds [26]PubMed.

Almost nobody reaches the potassium target

In NHANES 2009-2010, average US potassium intake was 2,640 mg a day against the 4,700 mg Adequate Intake then in force, and on the reporting day fewer than 1% of females and fewer than 25% of males reached it [27]PubMed. The Adequate Intake today is 3,400 mg for men and 2,600 mg for women, and in NHANES 2017-2018 only about a quarter of adults reached it [28]PubMed, which leaves about three in four short of the current standard. In 2003-2008 fewer than 2% of US adults met the potassium recommendation [29]DOI, and across 104 studies in 52 countries the mean global potassium intake was 2.25 g a day [30]PubMed.

The kidney, stress and magnesium

Potassium regulates cell membrane potential across all tissues and controls sodium reabsorption in the kidney's distal nephron [31]PubMed, through aldosterone-driven sodium channel handling [32]PubMed. Higher dietary potassium intake was associated with lower odds of chronic kidney disease across 104 studies [33]PubMed, and higher urinary potassium excretion with slower age-related decline in kidney function [34]PubMed. Stress runs through the same minerals. Four weeks of chronic stress and sleep deprivation reduced flow-mediated dilation and red blood cell magnesium in healthy young men [35]PubMed; potassium bicarbonate lowered total adrenal glucocorticoid secretion in men on a high-salt diet [36]PubMed; and a low-sodium, high-potassium diet improved depression, tension and vigour scores in a crossover trial of 94 adults [37]PubMed. A review describes stress depleting magnesium and low magnesium raising susceptibility to stress, a self-reinforcing loop [38]PubMed. Across 34 trials, magnesium supplementation was associated with modest reductions in blood pressure [39]PubMed, and higher dietary and serum magnesium were each associated with lower risk of cardiovascular events in a meta-analysis of 19 prospective cohorts [40]PubMed.

Vitamin E: the form is the point

The vitamin E requirement rises with polyunsaturated fat intake because alpha-tocopherol is a chain-breaking antioxidant that halts lipid peroxidation [41]PMC, and 800 IU a day increased LDL oxidation resistance and reduced lipid peroxidation markers in healthy adults [42]PubMed. The other forms have their own trials. A gamma-tocopherol-rich supplement improved brachial artery flow-mediated dilation and lowered TNF-alpha and myeloperoxidase beyond cessation alone in young smokers [43]PubMed; in healthy men, two months of tocotrienol-rich vitamin E improved arterial compliance without changing serum cholesterol [44]PubMed; and in a 5-week trial of 39 healthy adults, gamma-tocopherol lowered platelet activation and the 100 mg dose also reduced LDL cholesterol [45]PubMed. And the shortfall is wide: in NHANES 2005-2016, 84% of US adults fell below the estimated average requirement for vitamin E [46]DOI, and global surveys show over 82% of populations consume less than 15 mg a day [47]DOI.

Vitamin C and the oxidative load

Oxidative stress drives the early steps of plaque: increased endothelial permeability and LDL transport are driven by oxidative stress [8]PubMed. Vitamin C supplementation at a median 757.5 mg a day for six weeks reduced systolic blood pressure by about 3 mmHg in a meta-analysis [48]PubMed. At 1,000 mg a day it improved cholesterol and endothelial function markers in diabetic patients [49]DOI, and a week of vitamin C went with lower IL-6, TNF-alpha, CRP and systolic pressure in 58 healthy young adults in a polluted city [50]PubMed. In a randomized trial of 48 acute ischaemic stroke patients, 14 days of vitamin E 800 IU plus vitamin C 500 mg a day raised antioxidant capacity and lowered lipid peroxidation [51]PubMed.

The clot and the calcium

Nattokinase supplementation decreased plasma fibrinogen, factor VII and factor VIII in human subjects without significant adverse events [52]PubMed. In young adult smokers a nattokinase product increased fibrinolytic activity and shortened clot lysis time versus placebo [53]DOI, and in a hypertensive North American population it was associated with lower systolic and diastolic pressure [54]DOI. Vitamin K2 works on the other side of the problem, where the calcium goes. A meta-analysis found vitamin K2 slowed coronary calcification progression [55]PubMed; in a two-year placebo-controlled trial, daily menaquinone-7 was associated with roughly 29% less progression of coronary artery calcification [56]Source; and higher dietary menaquinone intake went with 57% lower coronary heart disease mortality over 10 years in 4,807 adults [57]PubMed. Together: in a 12-month study of 1,062 people taking nattokinase, lipid and artery measures improved, more so with added vitamin K2 [58]PubMed, and in atherosclerosis-prone mice natto with high vitamin K reduced lesion formation and foam cell accumulation [59]PubMed.

The food changed

This concern is older than the supplement aisle. In 1936, a passage was entered into the Congressional Record as U.S. Senate Document No. 264, a statement that began as a Rex Beach magazine article, warning that food raised on depleted soil no longer carries the minerals it should. It is a historical statement, not a peer-reviewed study, and it is not dressed up as one here. What makes it worth repeating is that the measured data echo it. USDA food-composition records for 43 garden crops showed measurable declines in several minerals and in protein between 1950 and 1999 [60]PubMed, UK records show substantial declines in several minerals in fruits and vegetables across nearly 80 years [61]Source, a review of food composition tables from 1940 to 2002 reports declining mineral content in foods [62]PubMed, and a review documents a 25-50% decline in the mineral content of commercial crops over 50 to 70 years [63]PubMed.

A blood test is not the cell

A blood test reads what circulates. Intracellular potassium deficiency can occur despite a normal serum potassium [64]PubMed, and serum magnesium, under 1% of body stores, can look normal despite depletion, with intracellular measures better reflecting status [65]PubMed. In adults over 65, red blood cell magnesium testing detected cellular depletion despite normal serum levels [66]DOI, and in 92 patients with type 2 diabetes a serum vitamin B12 that looked normal sat beside a lower red blood cell B12 [67]PubMed. Light-based measurement reads status in tissue the way a pulse oximeter reads oxygen: a finger-clip oximeter uses red and infrared light [68]Source. How that works for nutrients is on the Nutrition Diagnostics page.

What to do

The cardiac labs are not off because you are missing a medication. They are off because the cells of your heart, your arteries and your kidneys are missing the minerals and vitamins they run on. The minimum is six nutrients, each with the human trials above behind it: potassium, magnesium, vitamin E in its complete form, vitamin C, and nattokinase together with vitamin K2. Start with the one the numbers point to first, potassium, and build the rest around it. The page below names the stack, the labels and the prices, and the Lab Atlas shows where your own numbers sit.

Key Takeaways

  • Cardiovascular disease is the leading cause of death in the US and worldwide; stroke is second as a cause of death and disability globally.
  • Plaque starts where flow is low or turbulent and the vessel lining is damaged and more permeable; apoB-containing lipoproteins are trapped and oxidized in that wall.
  • Across randomized trials, higher potassium intake lowered blood pressure, and a higher sodium-to-potassium ratio was associated with higher cardiovascular risk; most adults fall short of the potassium target.
  • Vitamin E (in its gamma-tocopherol-rich and tocotrienol-rich forms), vitamin C and magnesium each have human trials on vascular function and blood pressure.
  • Nattokinase has human data on fibrinolysis and vitamin K2 on slowing coronary calcification; a blood test does not show what is inside the cells.
  1. 1.The burden of cardiovascular diseases among us states, 1990-2016 ; La carga de las enfermedades cardiovasculares entre nosotros estados, 1990-2016 (2018)Source
  2. 2.Ischemic Heart Disease (2013)DOI
  3. 3.Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2021)PubMed
  4. 4.Global Burden of Stroke (2018)PubMed
  5. 5.Low or oscillatory shear stress and endothelial permeability in atherosclerosis (2024)PubMed
  6. 6.Endothelial mechanobiology in atherosclerosis (2023)PubMed
  7. 7.Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis (2015)PubMed
  8. 8.Endothelial permeability, LDL deposition, and cardiovascular risk factors—a review (2017)PubMed
  9. 9.Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study (2000)Source
  10. 10.Endothelial Glycocalyx (2022)PubMed
  11. 11.Mechanosensing at the vascular interface (2014)PubMed
  12. 12.Rapid shear stress-dependent ENaC membrane insertion is mediated by the endothelial glycocalyx and the mineralocorticoid receptor (2022)PubMed
  13. 13.Impairment of endothelial glycocalyx in atherosclerosis and obesity (2023)PubMed
  14. 14.Endothelial glycocalyx integrity in health and disease: molecular mechanisms and stress-related vascular injury (2026)DOI
  15. 15.ROLE OF ENDOTHELIAL GLYCOCALYX DISRUPTION IN ATHEROSCLEROSIS PROGRESSION (2025)DOI
  16. 16.Potassium softens vascular endothelium and increases nitric oxide release (2009)PubMed
  17. 17.Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport (2017)PubMed
  18. 18.Why is LDL‐cholesterol bad cholesterol? (2008)DOI
  19. 19.[Dyslipidemia and atherosclerosis] (2011)PubMed
  20. 20.Lipid Oxidation Products and the Risk of Cardiovascular Diseases: Role of Lipoprotein Transport (2024)PubMed
  21. 21.Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials (2020)Source
  22. 22.Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses (2013)PMC
  23. 23.Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials (2017)PubMed
  24. 24.Estimated Dietary Na+/K+-Ratio and Cardiovascular Disease: A Systematic Review and Meta-Analysis (2025)DOI
  25. 25.Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies (2024)PubMed
  26. 26.Association between Usual Sodium and Potassium Intake and Blood Pressure and Hypertension among U.S. Adults: NHANES 2005–2010 (2013)PubMed
  27. 27.Potassium Intake of the U.S. Population: What We Eat in America, NHANES 2009-2010 (2012)PubMed
  28. 28.Potassium Intake of the U.S. Population: What We Eat in America, NHANES 2017-2018 (2022)PubMed
  29. 29.Sodium and potassium intakes among US adults: NHANES 2003–2008 (2012)DOI
  30. 30.Global mean potassium intake: a systematic review and Bayesian meta-analysis (2023)PubMed
  31. 31.A New Understanding of Potassium's Influence Upon Human Health and Renal Physiology (2023)PubMed
  32. 32.[Regulation of kidney on potassium balance and its clinical significance] (2023)PubMed
  33. 33.Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis (2021)PubMed
  34. 34.Urinary Potassium and Kidney Function Decline in the Population-Observational Study (2021)PubMed
  35. 35.Effect of chronic stress and sleep deprivation on both flow‐mediated dilation in the brachial artery and the intracellular magnesium level in humans (2004)PubMed
  36. 36.Glucocorticoid activity and metabolism with NaCl-induced low-grade metabolic acidosis and oral alkalization: results of two randomized controlled trials (2016)PubMed
  37. 37.Dietary electrolytes are related to mood (2008)PubMed
  38. 38.Magnesium Status and Stress: The Vicious Circle Concept Revisited (2020)PubMed
  39. 39.Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials (2016)PubMed
  40. 40.Magnesium and the Risk of Cardiovascular Events: A Meta-Analysis of Prospective Cohort Studies (2013)PubMed
  41. 41.Vitamin E function and requirements in relation to PUFA (2015)PMC
  42. 42.Effects of vitamin E depletion/repletion on biomarkers of oxidative stress in healthy aging (2004)PubMed
  43. 43.γ-Tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation (2013)PubMed
  44. 44.Arterial compliance and vitamin E blood levels with a self emulsifying preparation of tocotrienol rich vitamin E (2008)PubMed
  45. 45.Effects of gamma-tocopherol supplementation on thrombotic risk factors (2007)PubMed
  46. 46.Inadequacy of Immune Health Nutrients: Intakes in U.S. Adults, the 2005-2016 NHANES (2020)DOI
  47. 47.Vitamin E: Recommended Intake (2021)DOI
  48. 48.Vitamin C supplementation showed greater effects on systolic blood pressure in hypertensive and diabetic patients: an updated systematic review and meta-analysis of randomised clinical trials (2023)PubMed
  49. 49.Vitamin C intake potentially lowers total cholesterol to improve endothelial function in diabetic patients at increased risk of cardiovascular disease: A systematic review of randomized controlled trials (2022)DOI
  50. 50.Vascular benefits of vitamin C supplementation against fine particulate air pollution in healthy adults: A double-blind randomised crossover trial (2022)PubMed
  51. 51.Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke (2005)PubMed
  52. 52.Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects (2009)PubMed
  53. 53.Effects of Nattokinase fibrinol supplementation on Fibrinolysis and Atherogenesis (2009)DOI
  54. 54.Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial (2016)DOI
  55. 55.Vitamin K2 (MK-7) and coronary artery calcification, meta-analysisPubMed
  56. 56.Two years of menaquinone-7 supplementation and coronary artery calcification: a randomized clinical trial (2026)Source
  57. 57.Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study (2004)PubMed
  58. 58.Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants (2022)PubMed
  59. 59.Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cells (2023)PubMed
  60. 60.Changes in USDA food composition data for 43 garden crops, 1950 to 1999 (2004)PubMed
  61. 61.Historical changes in the mineral content of fruit and vegetables in the UK from 1940 to 2019: a concern for human nutrition and agriculture (2021)Source
  62. 62.The mineral depletion of foods available to us as a nation (1940-2002)--a review of the 6th Edition of McCance and Widdowson (2007)PubMed
  63. 63.An Alarming Decline in the Nutritional Quality of Foods: The Biggest Challenge for Future Generations' Health (2024)PubMed
  64. 64.Potassium Homeostasis and the Systemic Consequences of Intracellular Potassium Deficiency: From Molecular Mechanisms to Clinical Manifestations (2026)PubMed
  65. 65.Magnesium for the prevention and treatment of cardiovascular disease (2018)PubMed
  66. 66.Red blood cell magnesium content in individuals aged 65 years and older with asthenia and sarcopenia (2025)DOI
  67. 67.Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes (2013)PubMed
  68. 68.DEVICE FOR MEASURING OXYGENATION LEVEL AND PULSE FREQUENCY (2007)Source
Explore the full evidence in the library

Want the next one of\u00a0these?

The Signal is one email when there is something genuinely worth your attention -- written the way this post is, in plain language, with the studies behind it. No noise, no selling your address, and nothing to\u00a0buy.

The Signal, and nothing else -- no fixed schedule, only when there is something worth sending. We never sell or share your address, and you can unsubscribe in one click any time.

Cardiovascular disease is the leading cause of death, and plaque starts in a damaged vessel wall: where flow is low or turbulent, the lining loses its protection and cholesterol-carrying particles are trapped and oxidized. Human trials tie that wall to potassium and the sodium balance, magnesium, vitamin E, vitamin C, nattokinase and vitamin K2, and most adults fall short of the potassium target.

FAQ

Why is cardiovascular disease the number one killer?

It was the leading cause of death in the United States from 1990 to 2016 and worldwide it is responsible for 17.1 million deaths a year. Stroke caused 6.55 million deaths in 2019, and it is the second leading cause of death and disability globally.

Where does plaque start?

Areas of low or turbulent blood flow damage the arterial lining and allow cholesterol and immune cells in, which is the start of atherosclerosis. Retention and modification of apoB-containing lipoproteins in the wall are crucial early events.

What is the glycocalyx and why does it matter for the heart?

It is a carbohydrate layer on the inside of blood vessel walls that senses blood flow, regulates permeability and blood pressure, and acts with the epithelial sodium channel as a shear stress sensor. High cholesterol, atherosclerosis and obesity break it down, and higher shedding markers went with disease severity in 120 patients.

Why do potassium and sodium matter for blood pressure?

Pooling 32 randomized trials, higher potassium intake produced a dose-dependent reduction in blood pressure, and a higher sodium-to-potassium ratio was associated with a 10% higher risk of cardiovascular events and mortality across 24 studies. In NHANES 2017-2018 only about a quarter of adults reached the current potassium Adequate Intake.

What do the studies say about vitamin E, vitamin C, nattokinase and vitamin K2?

Vitamin E at 800 IU a day increased LDL oxidation resistance, vitamin C reduced systolic blood pressure by about 3 mmHg in a meta-analysis, nattokinase decreased plasma fibrinogen and factors VII and VIII, and vitamin K2 slowed coronary calcification progression in a meta-analysis.